CMMBNasdaqManufacturing

Chemomab Therapeutics Ltd. (CMMB) earnings date, market-implied expected move, and options open interest by expiry

1.13

Closed16:03 ET

Open0.95Volume224,831Mkt cap$133.5MP/E62.78EPS0.02

Day0.95 – 1.2072%52-wk0.92 – 3.1010%

CMMB

Chemomab Therapeutics Ltd.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Next report

—

Calendar

Last report

—

Largest filed tie

filed ties

13F top-10 QoQ

+12.98%

shares held · 10 largest managers

13F · Jun 30 '26123d lag

Top fund weight

—

No upcoming report date for Chemomab Therapeutics (CMMB). No implied move.

Implied vs realized

No reported quarters.

Implied vs realized

Positioning

No open-interest data.

Positioning

Linked exposure

No linked exposure.

Linked exposure

Revenue flow

No filed income statement.

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

NFP ×1.60· ±6.3% vs ±3.9% · 10 releases

eventrelease day|move|up · n×base

NFPjobs report±6.3%6 of 10×1.60

CPROFcorporate profits±5.4%3 of 12×1.39

PCEpersonal income & outlays±4.8%10 of 19×1.23

GDPgross domestic product±4.3%6 of 19×1.10

FOMCrate decision±3.5%9 of 24×0.89

PPIproducer prices±3.1%2 of 11×0.79

CPIconsumer prices±2.8%4 of 11×0.72

Bar = avg |move| to ±7% · tick = ±3.9% avg day · ×base = |move| ÷ ±3.9% · min 6 releases

Earnings history

EPS 0.04 · consensus —

Quarter	Reported	EPS	Consensus
Q1 FY23	—	0.04	—
Q3 FY22	—	0.04	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod